Cyclerion Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-11. The offering totals $24.3M, of which $24.3M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 44 people.
| Name | Role | Location |
|---|---|---|
| Kevin E Churchwell | Director | Cambridge, MA |
| George E Conrades | Director | Cambridge, MA |
| Marsha E Fanucci | Director | Cambridge, MA |
| Ole E Isacson | Director | Cambridge, MA |
| Stephanie E Lovell | Director | Cambridge, MA |
| Terrance E McGuire | Director | Cambridge, MA |
| Michael E Mendelsohn | Director | Cambridge, MA |
| Amy E Schulman | Director | New York, NY |
| Andreas E Busch | Executive Officer | Cambridge, MA |
| MARK G CURRIE | Executive Officer | CAMBRIDGE, MA |
| William G Huyett | Executive Officer | Cambridge, MA |
| Amy Schulman | Related Person | Cambridge, MA |
| Michael Mendelsohn | Related Person | Cambridge, MA |
| Stephanie Lovell | Related Person | Cambridge, MA |
| Terrance G McGuire | Director | Boston, MA |
| Errol M De Souza | Director | Cambridge, MA |
| Steven M Hyman | Director | Cambridge, MA |
| Terrance M McGuire | Director | Cambridge, MA |
| Peter M Hecht | Director | Cambridge, MA |
| Peter M Hecht | Executive Officer | Cambridge, MA |
| Anjeza M Gjino | Executive Officer | Cambridge, MA |
| Cheryl M Gault | Executive Officer | Cambridge, MA |
| Ole M Isacson | Director | Cambridge, MA |
| Terrance McGuire | Related Person | Cambridge, MA |
| Stephanie M Lovell | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-05-25 | D | $5.0M | $5.0M |
| 2021-06-17 | D | $18.0M | $18.0M |
| 2019-04-17 | D | $175.0M | $175.0M |